Hims & Hers Health, Inc. (HIMS)
| Market Cap | 6.07B -39.1% |
| Revenue (ttm) | 2.58B +28.0% |
| Net Income | -142.03M |
| EPS | -0.62 |
| Shares Out | 233.31M |
| PE Ratio | n/a |
| Forward PE | 75.38 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 13,168,399 |
| Open | 25.78 |
| Previous Close | 24.06 |
| Day's Range | 24.41 - 26.24 |
| 52-Week Range | 13.74 - 44.00 |
| Beta | 2.50 |
| Analysts | Hold |
| Price Target | 31.15 (+19.81%) |
| Earnings Date | Nov 9, 2026 |
About HIMS
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter ... [Read more]
Financial Performance
In 2025, Hims & Hers Health's revenue was $2.35 billion, an increase of 59.00% compared to the previous year's $1.48 billion. Earnings were $128.37 million, an increase of 1.85%.
Financial StatementsAnalyst Summary
According to 15 analysts, the average rating for HIMS stock is "Hold." The 12-month stock price target is $31.15, which is an increase of 19.81% from the latest price.
News
Polymarket Odds: Will RKLB, HIMS, TTD Beat Earnings on Monday?
On Monday, November 9, Rocket Lab ($RKLB), Hims & Hers ($HIMS), and Trade Desk ($TTD) will report their earnings. All three companies will report before the market opens. Traders are…
Hims & Hers Stock Jumps Ahead of Q3 Earnings on Nov. 9 — Here’s Why
Hims & Hers Health shares ($HIMS) jumped 6% to about $25 on Friday morning, erasing some of the roughly 10% drop the previous day. This followed a statement from the…
Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.
As part of the agreement, Hims said it won't compound GLP-1 medications like Zepbound in the future.
Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly Agreement
Hims & Hers stock rises after the company announces an agreement with Eli Lilly to offer the pharma giant's GLP-1s on its consumer platform.
Hims & Hers and Eli Lilly announce agreement to expand acces to Zepbound
Eli Lilly and Company (LLY) and Hims & Hers Health (HIMS) announced an agreement to help expand access to Zepbound, or tirzepatide, and Foundayo, or orforglipron. Through the agreement, eligible…
Eli Lilly, Hims & Hers enter pact to expand access to Zepbound and Foundayo
Eli Lilly (LLY) and Hims & Hers (HIMS) announced an agreement to help expand access to Zepbound and Foundayo. Through the agreement, eligible patients who receive a prescription from a…
Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
INDIANAPOLIS--(BUSINESS WIRE)--Eli Lilly and Company (NYSE: LLY) and Hims & Hers Health, Inc. (NYSE: HIMS) today announced an agreement to help expand access to Zepbound (tirzepatide) and Foundayo (or...
Hims & Hers Benefits Adds Grüns, Medjet, Tonal, and Viome for Whole-Body Health and Support When You Need It Most
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced four new partners joining Hims & Hers Benefits: Grüns®, Medjet®, Tonal™...
What Should Hims & Hers Health, Inc. Investors Know After 14.73% Stock Drop? The Law Offices of Frank R.
Lawsuit alleges Hims & Hers Health, Inc. made misleading statements to investors from August 4, 2025 to July 29, 2026; lead plaintiff motions are due November 2, 2026 LOS ANGELES, Oct. 30, 2026 /PRNew...
Kaplan Fox Advises Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Before the Deadline on November 2, 2026
NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HI...
Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (HIMS) to an Important Lead Plaintiff Deadline on November 2, 2026
New York, New York--(Newsfile Corp. - October 27, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Compa...
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors Who Suffered Losses to Seek a Leadership Role Before November 2, 2026
NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HI...
Kaplan Fox Announces That Hims & Hers Health, Inc. (HIMS) Investors Have Until November 2, 2026 to Seek Lead Plaintiff Status
New York, New York--(Newsfile Corp. - October 26, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Compa...
Kaplan Fox Encourages Hims & Hers Health, Inc. (HIMS) Investors to Contact the Firm About Their Legal Rights Before November 2, 2026
New York, New York--(Newsfile Corp. - October 23, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Compa...
Hims & Hers Asks Judge to Toss FTC Lawsuit over Subscription Payments and User Data
Online healthcare provider Hims & Hers Health ($HIMS) asked a federal judge to dismiss a lawsuit that accuses the company of misleading customers about subscription payments and sharing their private…
Kaplan Fox Reminds Investors of Hims & Hers Health, Inc. (HIMS) of the Deadline to Seek Lead Plaintiff Status on November 2, 2026
New York, New York--(Newsfile Corp. - October 22, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Compa...
Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men's Health Launch to Date
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced the launch of new injectable and oral testosterone replacement t...
Hims & Hers stock rises 5% as company launches men's weight care in Germany
Shares of Hims & Hers Health (HIMS) rose 5% on Tuesday after the telehealth company launched an online weight-management service for men in Germany, expanding its presence in Europe. The new offering ...
Kaplan Fox Encourages Hims & Hers Health, Inc. (HIMS) Investors With Significant Losses to Take Action Before the November 2, 2026 Lead Plaintiff Deadline
New York, New York--(Newsfile Corp. - October 20, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Compa...
What Does Hims & Hers Health, Inc.'s 14.73% Stock Drop Mean for Investors? The Law Offices of Howard G.
Suit alleges Hims & Hers Health, Inc. failed to disclose key facts to investors from August 4, 2025 through July 29, 2026; lead plaintiff deadline is November 2, 2026 BENSALEM TOWNSHIP, Pa., Oct. 19, ...
Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Act Ahead of the Lead Plaintiff Deadline on November 2, 2026
NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HI...
Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading global health and wellness platform, today announced that it will report third quarter 2026 financial ...
Hers Launches in Australia, Built to Care for the Whole Woman
SYDNEY--(BUSINESS WIRE)--Hims & Hers, the leading global health and wellness platform, today announced the official launch of Hers in Australia, bringing its personalised care platform to women nation...
Kaplan Fox & Kilsheimer LLP Encourages Hims & Hers Health, Inc. (HIMS) Investors With Losses to Seek Appointment as Lead Plaintiff Before November 2, 2026
New York, New York--(Newsfile Corp. - October 8, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Compan...
Hims & Hers Names Jon Franklin as Chief Accounting Officer
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced Jon Franklin has joined the company as Chief Accounting Officer....